Showing results (1-10 of 203) with videos related to
Sort By:
Pageof 21
Clinical Drug Investigation|November 3, 2017
Tofacitinib: A New Oral Therapy for PsoriasisAlexandra Azevedo, Tiago TorresDermatology Online Journal|January 26, 2019
The successful treatment with ixekizumab in a multi-failure psoriasis patientAlexandra Azevedo, Tiago TorresDrugs in Context|March 24, 2020
Management of psoriasis in pregnancy - a review of the evidence to dateClara Ferreira, Alexandra Azevedo, Miguel Nogueira, et al.Acta Medica Portuguesa|October 18, 2018
Biosimilar Agents for Psoriasis Treatment: The Perspective of Portuguese PatientsAlexandra Azevedo, Andreia Bettencourt, Manuela Selores, et al.Drugs|August 4, 2017
Selective Interleukin-23 p19 Inhibition: Another Game Changer in Psoriasis? Focus on RisankizumabTiago TorresActa Dermatovenerologica Croatica : ADC|September 18, 2014
Psoriasis and metabolic syndromeRita Sales, Tiago TorresDrugs in Context|June 28, 2021
Bimekizumab: the new drug in the biologics armamentarium for psoriasisEgídio Freitas, Tiago TorresDermatology and Therapy|March 3, 2026
High-Dose, Extended Half-Life IL-23 Inhibitors: the Next Big Step in Psoriasis Care?Tiago Torres, Andrew BlauveltAmerican Journal of Clinical Dermatology|March 12, 2026
Icotrokinra: An Oral Interleukin-23 Receptor Antagonist Peptide for the Treatment of PsoriasisCésar Ferreira, Tiago TorresPageof 21